HAITONG INT'L: Bullish on the bottom reversal of the Traditional Chinese Medicine Industry, with the State-owned Enterprise Reform and mergers and acquisitions resonating in development.

As aging continues to intensify, the demand in the Silver economy and chronic disease medication-related fields is viewed as Bullish.

Zhitong FinanceDec 13 01:47 ET

Mayinglong Pharmaceutical Group's MYL Ointment Gets Regulatory Approval for Clinical Trials

MT NewswiresDec 10 05:57 ET

Mayinglong Pharmaceutical Group (600993.SH): MYL ointment (Musk Hemostatic Analgesic Ointment, tentative) approved for clinical trials.

Mayinglong Pharmaceutical Group (600993.SH) has announced that recently, the company received approval from the National Medical Products Administration for...

Zhitong FinanceDec 6 02:49 ET

Mayinglong Pharmaceutical Group Co., Ltd.'s (SHSE:600993) Largest Shareholders Are Individual Investors Who Were Rewarded as Market Cap Surged CN¥664m Last Week

Simply Wall StNov 30 21:18 ET

There Is A Reason Mayinglong Pharmaceutical Group Co., Ltd.'s (SHSE:600993) Price Is Undemanding

Simply Wall StNov 12 17:40 ET

Ma Yinglong Report for the Third Quarter of 2024

SZSIOct 25 12:00 ET · Announcements